APA

Uronis H. E., Cushman S. M., Bendell J. C., Blobe G. C., Morse M. A., Nixon A. B., Dellinger A., Starr M. D., Li H., Meadows K., Gockerman J., Pang H. & Hurwitz H. I. (20140415). A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. : Cancer medicine.

Chicago

Uronis Hope E, Cushman Stephanie M, Bendell Johanna C, Blobe Gerard C, Morse Michael A, Nixon Andrew B, Dellinger Andrew, Starr Mark D, Li Haiyan, Meadows Kellen, Gockerman Jon, Pang Herbert and Hurwitz Herbert I. 20140415. A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. : Cancer medicine.

Harvard

Uronis H. E., Cushman S. M., Bendell J. C., Blobe G. C., Morse M. A., Nixon A. B., Dellinger A., Starr M. D., Li H., Meadows K., Gockerman J., Pang H. and Hurwitz H. I. (20140415). A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. : Cancer medicine.

MLA

Uronis Hope E, Cushman Stephanie M, Bendell Johanna C, Blobe Gerard C, Morse Michael A, Nixon Andrew B, Dellinger Andrew, Starr Mark D, Li Haiyan, Meadows Kellen, Gockerman Jon, Pang Herbert and Hurwitz Herbert I. A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. : Cancer medicine. 20140415.